Media hyping and the "Herceptin access story": An analysis of Canadian and UK newspaper coverage

Healthcare Policy

Volumn 4, Issue 3, 2009, Pages

  Abelson, Julia ^a   Collins, Patricia A ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TRASTUZUMAB;

ARTICLE; CANADA; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FUNDING; HEALTH CARE POLICY; HUMAN; MEDICAL INFORMATION; MULTICENTER STUDY; PUBLICATION; PUBLISHING; UNITED KINGDOM;

EID: 67650564840     PISSN: None     EISSN: 17156572     Source Type: Journal    
DOI: 10.12927/hcpol.2009.20474     Document Type: Article

References (63)

1. Abraham, C. 2005 (August 22). "Cancer Clinic Opens the Door for Private Care." The Globe and Mail: A1.
2. Anonymous. 2005. "Herceptin and Early Breast Cancer: A Moment for Caution." Lancet 366: 1673 (Pubitemid 41587432)
3. Arvai, J.L. and M.J. Mascarenhas. 2001. "Print Media Framing of the Environmental Movement in a Canadian Forestry Debate." Environmental Management 27(5): 705-714 (Pubitemid 32335536)
4. Bartlett, C., J. Sterne and M. Egger. 2002. "What Is Newsworthy? Longitudinal Study of the Reporting of Medical Research in Two British Newspapers." British Medical Journal 325(7355): 81-84. (Pubitemid 34774882)
5. Benelli, E. 2003. "The Role of Media in Steering Public Opinion on Healthcare Issues." Health Policy 63(2): 179-186 (Pubitemid 36132303)
6. Boseley, S. 2006 ( June 9). "Charities Welcome Draft Approval for Breast Cancer Drug." The Guardian: 6.
7. Braun, S. 2003. "The History of Breast Cancer Advocacy." Breast Journal 9: S101-3.
8. Brodie, M., L. Brady and D.E. Altman. 1998. "Media Coverage of Managed Care: Is There a Negative Bias?" Health Affairs 17(1): 9-25. (Pubitemid 128465103)
9. Bubela, T.M. and T.A. Caulfield. 2004. "Do the Print Media 'Hype' Genetic Research? A Comparison of Newspaper Stories and Peer-Reviewed Research Papers." Canadian Medical Association Journal 170: 1399-1407 (Pubitemid 38594632)
10. Canadian Institute for Health Information (CIHI). 2008. Drug Expenditure in Canada, 1985 to 2007. Ottawa: Author.
11. Cassels, A., M.A. Hughes, C. Cole, B. Mintzes, J. Lexchin and J.P. McCormack. 2003. "Drugs in the News: An Analysis of Canadian Newspaper Coverage of New Prescription Drugs." Canadian Medical Association Journal 168: 1133-1137 (Pubitemid 36543224)
12. Cassels, A. and J. Lexchin. 2008. "How Well Do Canadian Media Outlets Convey Medical Treatment Information? Initial Findings from a Year and a Half of Media Monitoring by Media Doctor Canada." Open Medicine 2(1): 20-23.
13. Chapman, J. 2006 ( January 26). "Postcode Lottery 'Denies Cancer Victims Best Care'." The Daily Mail: 27.
14. Chen, X. and L.L. Siu. 2001. "Impact of the Media and the Internet on Oncology: Survey of Cancer Patients and Oncologists in Canada." Journal of Clinical Oncology 19: 4291-4297 (Pubitemid 33096776)
15. Collier, J. 2006. "Panorama: Herceptin: Wanting the Wonder Drug." British Medical Journal 332(7537): 368.
16. Collins, P., J. Abelson, H. Pyman and J. Lavis. 2006. "Are We Expecting Too Much from Print Media: An Analysis of Newspaper Coverage of the 2002 Canadian Healthcare Reform Debate." Social Science and Medicine 63: 89-112. (Pubitemid 44269010)
17. Cook, E. 2005 (September 19). "Cancer Victim Sues to Get Wonder Drug on the NHS." The Daily Mail: 5.
18. Cookson, C. 2005 (November 11). "Medical Opinion Split on Use of Herceptin for Early Breast Cancer." The Financial Times: 6.
19. Cooper, C.P. and D. Yukimura. 2002. "Science Writers' Reactions to a Medical 'Breakthrough' Story." Social Science and Medicine 54: 1887-1896 (Pubitemid 34462164)
20. Dearing, J.W. and E.M. Rogers. 1996. Agenda-Setting. Thousand Oaks, CA: Sage Publications.
21. Driedger, S.M. and J.D. Eyles. 2003. "Different Frames, Different Fears: Communicating about Chlorinated Drinking Water and Cancer in the Canadian Media." Social Science and Medicine 56: 1279-1293 (Pubitemid 36216326)
22. Friend, D., J. Keelet, D. Liebman and F. Sutherland, eds. 1997. Canadian Dictionary of the English Language. Scarborough, ON: ITP Nelson.
23. Geller, G., B.A. Bernhardt and N.A. Holtzman. 2002. "The Media and Public Reaction to Genetic Research." Journal of the American Medical Association 287: 773. (Pubitemid 34250466)
24. Grove, M.L. 2005. "Adjuvant Trastuzumab for Breast Cancer: An Increasingly Common Ethical and Economic Conundrum." British Medical Journal 331(7526): 1202.
25. Hall, S. 2006 (April 10). "English Women Lose Out in Herceptin's 'Postcode Lottery'." The Guardian: 5.
26. Hortobagyi, G.N. 2005. "Trastuzumab in the Treatment of Breast Cancer." New England Journal of Medicine 353(16): 1734-1736
27. Hume, M. 2005 ( July 12). "BC Agrees to Pay for Vaunted Cancer Drug." The Globe and Mail: A6.
28. Jackson, A. 2006 (May 25). "Decision Awaited on Breast Cancer Drug." The Financial Times: 4.
29. Keidan, J. 2007. "Sucked into the Herceptin Maelstrom." British Medical Journal 334(7583): 18.
30. Kondro, W. and B. Sibbald. 2005. "Patient Demand and Politics Push Herceptin Forward." Canadian Medical Association Journal 173(4): 347-348
31. Lloyd, D. 2005 ( July 14). "Why the Drug Delay?" The Globe and Mail: A16.
32. Mayor, S. 2006. "NICE Approves Trastuzumab for Early Stage Breast Cancer." British Medical Journal 332: 1409.
33. McMahon, M., S. Morgan and C. Mitton. 2006. "The Common Drug Review: A Nice Start for Canada?" Health Policy 77(3): 339-351 (Pubitemid 43946522)
34. Meikle, J. 2005 (October 26). "Hewitt Clears Way for Use of Costly Breast Cancer Drug." The Guardian: 4.
35. Moore, O. 2006 (April 12). "The Globe Wins Michener Award." The Globe and Mail: A8.
36. Moynihan, R., L. Bero, D. Ross-Degnan, D. Henry, K. Lee, J. Watkins, C. Mah and S.B. Soumerai. 2000. "Coverage by the News Media of the Benefits and Risks of Medications." New England Journal of Medicine 342: 1645-1650 (Pubitemid 30341535)
37. Niederlaender, E. 2006. Causes of Death in the EU. Luxembourg: Eurostat.
38. Piccart-Gebhart, M.J., M. Procter, B. Leyland-Jones, A. Goldhirsch, M. Untch, I. Smith, L. Gianni, J. Baselga, R. Bell, C. Jackisch, D. Cameron, M. Dowsett, C.H. Barrios, G. Steger, C.S. Huang, M. Andersson, M. Inbar, M. Lichinitser, I. Lang, U. Nitz, H. Iwata, C. Thomssen, C. Lohrisch, T.M. Suter, J. Ruschoff, T. Suto, V. Greatorex, C. Ward, C. Straehle, E. McFadden, M.S. Dolci and R.D. Gelber.. 2005. "Trastuzumab after Adjuvant Chemotherapy in Her2-Positive Breast Cancer." New England Journal of Medicine 353(16): 1659-1672 (Pubitemid 41464705)
39. Priest, L. 2005a ( June 7). "New Cancer Drug Limited to Few." The Globe and Mail: A1.
40. Priest, L. 2005b ( June 8). "A Case of Growing Impatience." The Globe and Mail: A1.
41. Priest, L. 2005c ( June 24). "Ontario Will Fast-Track Breast Cancer Drug." The Globe and Mail: A1.
42. Priest, L. 2005d ( June 27). "Cancer-Drug Delay Could Kill Women, Study Says." The Globe and Mail: A3.
43. Priest, L. 2005e ( July 22). "Ontario Will Make Herceptin Widely Available." The Globe and Mail: A1.
44. Ransohoff, D.F. and R.M. Ransohoff. 2001. "Sensationalism in the Media: When Scientists and Journalists May Be Complicit Collaborators." Effective Clinical Practice 4: 185-188
45. Romond, E. 2005. "Advances in Monoclonal Antibody Therapy for Breast Cancer: Joint Analysis of Nsabp-B-31 and Ncctg-N9831." Paper presented at the 2005 Association of Clinical Oncologists Annual Meeting (Virtual Meeting), Orlando, Florida.
46. Romond, E.H., E.A. Perez, J. Bryant, V. J. Suman, C.E. Geyer, Jr., N.E. Davidson, E. Tan-Chiu, S. Martino, S. Paik, P.A. Kaufman, S.M. Swain, T.M. Pisansky, L. Fehrenbacher, L.A. Kutteh, V.G. Vogel, D.W. Visscher, G. Yothers, R.B. Jenkins, A.M. Brown, S.R. Dakhil, E.P. Mamounas, W.L. Lingle, P.M. Klein, J.N. Ingle and N. Wolmark. 2005. "Trastuzumab Plus Adjuvant Chemotherapy for Operable Her2-Positive Breast Cancer." New England Journal of Medicine 353(16): 1673-1684 (Pubitemid 41464706)
47. Scheule, D. 1999. "Framing as a Theory of Media Effects." Journal of Communication 49: 103-122
48. Schwartz, L.M. and S. Woloshin. 2004. "The Media Matter: A Call for Straightforward Medical Reporting." Annals of Internal Medicine 140: 226-228 (Pubitemid 38155654)
49. Schwartz, L.M., S. Woloshin and L. Baczek. 2002. "Media Coverage of Scientific Meetings: Too Much, Too Soon?" Journal of the American Medical Association 287(21): 2859-2863 (Pubitemid 34591985)
50. Schwitzer, G. 2003. "How the Media Left the Evidence Out in the Cold." British Medical Journal 326: 1403-1404
51. Seale, C. 2003. "Health and Media: An Overview." Sociology of Health and Illness 25: 513-531
52. Smith, D.E., A.J. Wilson and D.A. Henry. 2005. "Monitoring the Quality of Medical News Reporting: Early Experience with Media Doctor." Medical Journal of Australia 183(4): 190-193 (Pubitemid 41150325)
53. Smith, M. 2005. "Oh, Canada: Public Outcry Pushed Demand for Trastuzumab for Early-Stage Breast Cancer." Journal of the National Cancer Institute 97(18): 1327. (Pubitemid 41487797)
54. Statistics Canada. 2004. "Age-Standardized Mortality Rates by Selected Causes, by Sex, 2007." Retrieved January 5, 2009. 〈http://www40.statcan.ca/l01/cst01/health30a.htm〉.
55. Tait, N. 2006 (February 16). "Cancer Sufferer Loses Drug Fight." The Financial Times: 5.
56. Thomas, P. 2006. "Herceptin: Clinical Trial by Media - It Doesn't Cure Cancer, It Has Worrying Adverse Effects, and Is Very Expensive. So How Did Herceptin Become the Latest Breast Cancer Miracle Drug?" Ecologist 36(7): 14-21.
57. Thompson, D., ed. 1995. The Concise Oxford Dictionary (9th ed.). New York: Oxford University Press.
58. Tuma, R.S. 2005. "Trastuzumab Trials Steal Show at ASCO Meeting." Journal of the National Cancer Institute 97(12): 870-871 (Pubitemid 41417932)
59. Wheldon, J. 2006 (February 6). "Mother Who Was Refused New Cancer Drug Begins Court Battle." The Daily Mail: 20.
60. Wilson, E.C.F. 2005. "Trastuzumab for Early Breast Cancer Raises Important Issues." British Medical Journal 331(7523): 1023. (Pubitemid 41552459)
61. Woloshin, S. and L.M. Schwartz. 2002. "Press Releases: Translating Research into News." Journal of the American Medical Association 287(21): 2856-2858 (Pubitemid 34591984)
62. Woloshin, S. and L.M. Schwartz. 2006a. "Media Reporting on Research Presented at Scientific Meetings: More Caution Needed." Medical Journal of Australia 184(11): 576-580 (Pubitemid 43950029)
63. Woloshin, S. and L.M. Schwartz. 2006b. "What's the Rush? The Dissemination and Adoption of Preliminary Research Results." Journal of the National Cancer Institute 98(6): 372-373